Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer

By Buzdar Aman   Chlebowski Rowan   Cuzick Jack   Duffy Sean   Forbes John   Jonat Walter   Ravdin Peter    

Current Medical Research and Opinion, Vol. 22, Iss. 8, 2006-08 ,pp. : 1575-1585

Informa Healthcare

Access to resources Recommend Favorite

Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer

By Ligibel Jennifer A   Winer Eric P  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 89-97

Future Medicine

Access to resources Recommend Favorite

Eligibility, Compliance and Persistence of Sequential Therapy with Aromatase Inhibitors following 2–3 Years of Tamoxifen in Endocrine Adjuvant Breast Cancer Therapy

By  

Oncology, Vol. 81, Iss. 3-4, 2011-10 ,pp. : 151-157

Karger

Access to resources Recommend Favorite

Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women

By Mouridsen Henning T.  

Current Medical Research and Opinion, Vol. 22, Iss. 8, 2006-08 ,pp. : 1609-1621

Informa Healthcare

Access to resources Recommend Favorite

Optimal Treatment Strategies in Hormone-Responsive Early Breast Cancer: The Role of Aromatase Inhibitors

By  

Oncology Research and Treatment, Vol. 30, Iss. 1-2, 2007-01 ,pp. : 55-64

Karger

Access to resources Recommend Favorite